SCHEMBL2117149

SCHEMBL2117149

OC1CCCCC(N2CCC(O)CC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
SLC18A3 Q16572 2/20 0.42
PHGDH O43175 1/20 0.39
MGLL Q99685 1/20 0.39
OPRM1 P35372 2/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OGFRL1 Q5TC84 1/20 0.38
HRH3 Q9Y5N1 3/20 0.36
POLB P06746 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
PDE7A Q13946 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
HTR6 P50406 1/20 0.34
ABCB1 P08183 1/20 0.34
OPRL1 P41146 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2114280 0.95 TSHR (0.41) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL987309 0.93 TSHR (0.47) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL985944 0.90 PHGDH (0.47) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL2115222 0.90 TSHR (0.45) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL2114984 0.90 GPR119 (0.40) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL2117147 0.89 TSHR (0.42) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL20817364 0.88 TSHR (0.46) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL18566741 0.88 TSHR (0.46) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL429615 0.87 TSHR (0.40) TSHRSLC18A3PHGDHMGLLOPRM1
SCHEMBL446116 0.87 GPR119 (0.42) TSHRSLC18A3PHGDHMGLLOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158652-B2 1-Difluoromethyl-5-{4-[3-(1-piperidinyl)propoxy]phenyl}-2(1H)-pyridone; compounds act as histamine-H3 receptor antagonistic substances or inverse-agonistic substances; useful as preventives or remedies for various circular system diseases, nervous system diseases, metabolic system diseases MSD K.K. (JP) 2012-04-17 US disclosed
US-20080269287-A1 Substituted Pyridone Derivative MSD K.K. (JP) 2008-10-30 US disclosed
EP-1820797-A1 SUBSTITUTED PYRIDONE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269287-A1 Substituted Pyridone Derivative HRH3, HRH4, HRH1 TSHR 146/4885SLC18A3 2608/4885PHGDH 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.